From GlobeNewswire: 2025-04-01 10:41:00

The coagulation market is projected to grow from $6.29 billion in 2022 to $10.85 billion by 2030, with a 7.0% CAGR. Key players like Siemens Healthineers AG and Roche are driving growth with new product launches. The market is fueled by the rising prevalence of blood disorders, with North America leading in revenue.

Blood disorders like hemophilia and deep vein thrombosis are on the rise, with millions affected globally. Market players are implementing strategies to enhance patient care. Recent product launches by Roche, HORIBA Medical, and Trivitron Healthcare are aimed at improving diagnostic capabilities and treatment options for blood disorders.

Geographically, North America dominates the coagulation market, followed by Europe and APAC. Asia Pacific is expected to show the highest growth rate. The market is segmented by disease indication, type, offering, technology, and end user, offering a wide range of opportunities for stakeholders in the industry.

The rising prevalence of blood disorders and the increasing adoption of advanced diagnostics are driving the coagulation market forward. With continuous advancements in therapies and devices, the market is expected to see significant growth in the coming years. Stakeholders can leverage insights from reports like those from The Insight Partners for strategic decision-making.



Read more at GlobeNewswire: Coagulation Market Size Set to Reach USD 10.85 Billion by